From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease
Talita P.C. Chierrito(Universidade de São Paulo), Ivone Carvalho(University of the Sunshine Coast), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Willian Orlando Castillo Ordoñez(Universidade de São Paulo), F. Javier Cañada(Centro de Investigaciones Biológicas Margarita Salas), Víctor Sebastián-Pérez(Centro de Investigaciones Biológicas Margarita Salas), Nuria E. Campillo(Centro de Investigaciones Biológicas Margarita Salas), Catarina Satie Takahashi, Jesús Jiménez‐Barbero(Ikerbasque), Carlos Requeña(Centro de Investigaciones Biológicas Margarita Salas), Susimaire Pedersoli-Mantoani(Universidade de São Paulo), Carlos Roca(Centro de Investigaciones Biológicas Margarita Salas), Concepción Pérez(Instituto de Química Médica), Elza Tiemi Sakamoto‐Hojo(Universidade de Ribeirão Preto), Natália Moreira(Universidade de São Paulo)
Cited by 54
Related Papers
Carrageenans: Biological properties, chemical modifications and structural analysis – A review
|Carbohydrate Polymers|2009|1.4k
α- and β-Glucosidase inhibitors: chemical structure and biological activity
|Tetrahedron|2006|541
Multivalent glycoconjugates as anti-pathogenic agents
|Chemical Society Reviews|2012|534
Diketopiperazines: biological activity and synthesis
|Tetrahedron|2007|393